Elevance Health, Inc.
ELVAPI behind this page
ELV Q1 2026 request
Playground key active
/api/financials?ticker=ELV&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Premiums Earned Net (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 779 | 1,500 | -48.1% |
| Health Benefits · Operating Segments | 40,452 | 39,588 | +2.2% |
| Total Carelon · Operating Segments | 779 | 1,500 | -48.1% |
Show — breakouts |
|||
| Premiums Earned Net | 41,024 | 40,887 | +0.3% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -207 | -201 | -3.0% |
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 6,225 | 5,809 | +7.2% |
| Product · CarelonRx | 6,225 | 5,809 | +7.2% |
| Product · Total Carelon | 6,225 | 5,809 | +7.2% |
| Service fees | 2,245 | 2,069 | +8.5% |
| Service fees · Carelon Services | 203 | 223 | -9.0% |
| Service fees · CarelonRx | 4 | 3 | +33.3% |
| Service fees · Health Benefits | 2,038 | 1,843 | +10.6% |
| Service fees · Total Carelon | 207 | 226 | -8.4% |
| Operating Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 6,383 | 4,813 | +32.6% |
| Carelon Services · Operating Segments | 982 | 1,723 | -43.0% |
| Carelon Services · Operating Segments | 7,365 | 6,536 | +12.7% |
| CarelonRx · Operating Segments | 4,371 | 4,304 | +1.6% |
| CarelonRx · Operating Segments | 6,229 | 5,812 | +7.2% |
| CarelonRx · Operating Segments | 10,600 | 10,116 | +4.8% |
| Corporate And Other · Operating Segments | 4 | 165 | -97.6% |
| Corporate And Other · Operating Segments | 4 | 165 | -97.6% |
| Health Benefits · Operating Segments | 42,490 | 41,431 | +2.6% |
| Health Benefits · Operating Segments | 42,490 | 41,431 | +2.6% |
| Reportable Segments | 49,494 | 48,765 | +1.5% |
| Total Carelon · Operating Segments | 10,754 | 9,117 | +18.0% |
| Total Carelon · Operating Segments | 7,211 | 7,535 | -4.3% |
| Total Carelon · Operating Segments | 17,965 | 16,652 | +7.9% |
Show — breakouts |
|||
| Operating Revenue | 49,494 | 48,765 | +1.5% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -10,965 | -9,483 | -15.6% |
| Intersegment Elimination · Operating revenue - affiliated | -10,758 | -9,282 | -15.9% |
| Intersegment Elimination · Operating revenue - unaffiliated | -207 | -201 | -3.0% |
Show Major Customers breakouts |
|||
| Operating revenue - unaffiliated | 49,494 | 48,765 | +1.5% |
| Net Investment Income (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segments | 765 | 590 | +29.7% |
Show — breakouts |
|||
| Net Investment Income | 765 | 590 | +29.7% |
| Net Losses Gains On Financial Instruments (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segments | -78 | -464 | +83.2% |
Show — breakouts |
|||
| Net Losses Gains On Financial Instruments | -78 | -464 | +83.2% |
| Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segments | 50,181 | 48,891 | +2.6% |
Show — breakouts |
|||
| Revenue | 50,181 | 48,891 | +2.6% |
| Policyholder Benefits And Claims Incurred Net (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 6,085 | 5,319 | +14.4% |
| Corporate And Other · Operating Segments | 9 | 10 | -10.0% |
| Health Benefits · Operating Segments | 35,453 | 34,393 | +3.1% |
| Total Carelon · Operating Segments | 6,085 | 5,319 | +14.4% |
Show — breakouts |
|||
| Policyholder Benefits And Claims Incurred Net | 35,615 | 35,312 | +0.9% |
Show Legal Entity breakouts |
|||
| Mosaic Health · Equity Method Investee | 193 | 175 | +10.3% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -5,932 | -4,410 | -34.5% |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Liberty Dental | 133 | 146 | -8.9% |
| Cost of Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| CarelonRx · Operating Segments | 9,830 | 9,284 | +5.9% |
| Total Carelon · Operating Segments | 9,830 | 9,284 | +5.9% |
Show — breakouts |
|||
| Cost of Revenue | 5,463 | 4,983 | +9.6% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -4,367 | -4,301 | -1.5% |
| Selling, General & Administrative (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 810 | 726 | +11.6% |
| CarelonRx · Operating Segments | 188 | 230 | -18.3% |
| Corporate And Other · Operating Segments | 1,118 | 295 | +279.0% |
| Health Benefits · Operating Segments | 4,880 | 4,821 | +1.2% |
| Total Carelon · Operating Segments | 998 | 956 | +4.4% |
Show — breakouts |
|||
| Selling, General & Administrative | 6,330 | 5,300 | +19.4% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -666 | -772 | +13.7% |
| Interest Expense (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segments | 357 | 344 | +3.8% |
Show — breakouts |
|||
| Interest Expense | 357 | 344 | +3.8% |
| Amortization Of Intangible Assets (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segments | 112 | 155 | -27.7% |
Show — breakouts |
|||
| Amortization Of Intangible Assets | 112 | 155 | -27.7% |
| Benefits Losses And Expenses (Q) | — | — | — |
Show — breakouts |
|||
| Benefits Losses And Expenses | 47,877 | 46,094 | +3.9% |
| Income Before Taxes (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segments | 2,304 | 2,797 | -17.6% |
Show — breakouts |
|||
| Income Before Taxes | 2,304 | 2,797 | -17.6% |
| Income Tax Expense (Benefit) (Q) | — | — | — |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | 544 | 613 | -11.3% |
| Net Income (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | -4 | 1 | -500.0% |
| Retained Earnings | 1,764 | 2,183 | -19.2% |
Show — breakouts |
|||
| Net Income | 1,760 | 2,184 | -19.4% |
| Net Income Loss Attributable To Noncontrolling Interest (Q) | — | — | — |
Show — breakouts |
|||
| Net Income Loss Attributable To Noncontrolling Interest | 4 | -1 | +500.0% |
| Net Income (Q) | — | — | — |
Show — breakouts |
|||
| Net Income | 1,764 | 2,183 | -19.2% |
| EPS (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | 8.03 | 9.64 | -16.7% |
| EPS (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | 8 | 9.61 | -16.8% |
| Common Stock Dividends Per Share Declared (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock Dividends Per Share Declared | 1.72 | 1.71 | +0.6% |
| Operating Income (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 470 | 491 | -4.3% |
| CarelonRx · Operating Segments | 582 | 602 | -3.3% |
| Corporate And Other · Operating Segments | -1,123 | -140 | -702.1% |
| Health Benefits · Operating Segments | 2,157 | 2,217 | -2.7% |
| Reportable Segments | 2,086 | 3,170 | -34.2% |
| Total Carelon · Operating Segments | 1,052 | 1,093 | -3.8% |
Show — breakouts |
|||
| Operating Income | 2,086 | 3,170 | -34.2% |
| Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 1,474 | 2,419 | -39.1% |
| Wtd Avg Shares (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Basic) | 219.8 | 226.4 | -2.9% |
| Wtd Avg Shares (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | 220.4 | 227.2 | -3.0% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 (Q) | — | — | — |
Show — breakouts |
|||
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 34,553 | 34,288 | +0.8% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 9,657 | 7,500 | +28.8% |
| Available For Sale Securities Debt Securities Current (Q) | — | — | — |
Show — breakouts |
|||
| Available For Sale Securities Debt Securities Current | 25,905 | 25,437 | +1.8% |
| Equity Securities Fv Ni (Q) | — | — | — |
Show Financial Instrument breakouts |
|||
| Common equity securities | 35 | 32 | +9.4% |
| Exchange Traded Funds | 1,428 | 621 | +130.0% |
| Private Equity Funds | 48 | 62 | -22.6% |
Show — breakouts |
|||
| Equity Securities Fv Ni | 1,511 | 715 | +111.3% |
| Premiums Receivable At Carrying Value (Q) | — | — | — |
Show — breakouts |
|||
| Premiums Receivable At Carrying Value | 11,525 | 10,359 | +11.3% |
| Self Funded Receivables Net (Q) | — | — | — |
Show — breakouts |
|||
| Self Funded Receivables Net | 5,098 | 5,246 | -2.8% |
| Other Receivables (Q) | — | — | — |
Show — breakouts |
|||
| Other Receivables | 6,167 | 6,576 | -6.2% |
| Other Assets Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Assets Current | 7,169 | 5,288 | +35.6% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 67,032 | 61,121 | +9.7% |
| Non-Current Assets | |||
| Property, Plant & Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Property, Plant & Equipment | 4,657 | 4,617 | +0.9% |
| Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Goodwill | 28,340 | — | — |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 2,582 | — | — |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 125,827 | 119,717 | +5.1% |
| Other Assets | |||
| Other Long Term Investments (Q) | — | — | — |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Common equity securities | 4 | — | — |
| Fair Value Inputs Level3 · Estimate Of Fair Value Fair Value Disclosure | 765 | — | — |
Show Financial Instrument breakouts |
|||
| Common equity securities | 4 | — | — |
Show — breakouts |
|||
| Other Long Term Investments | 11,009 | — | — |
Show Legal Entity breakouts |
|||
| Mosaic Health · Line Of Credit | 282 | — | — |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Liberty Dental | 145 | — | — |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure · Fair Value Measurements Nonrecurring | 787 | — | — |
| Estimate Of Fair Value Fair Value Disclosure · Fair Value Measurements Recurring | 765 | — | — |
Show Investment Type breakouts |
|||
| Other Long Term Investments | 1,742 | — | — |
| Intangible Assets Net Excluding Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Intangible Assets Net Excluding Goodwill | 11,093 | 11,940 | -7.1% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense (Q) | — | — | — |
Show — breakouts |
|||
| Liability For Claims And Claims Adjustment Expense | 18,425 | 16,812 | +9.6% |
| Other Policyholder Funds (Q) | — | — | — |
Show — breakouts |
|||
| Other Policyholder Funds | 3,857 | 3,796 | +1.6% |
| Unearned Premiums (Q) | — | — | — |
Show — breakouts |
|||
| Unearned Premiums | 1,759 | 1,640 | +7.3% |
| Accounts Payable And Accrued Liabilities Current (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable And Accrued Liabilities Current | 6,209 | 7,131 | -12.9% |
| Short Term Borrowings (Q) | — | — | — |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level2 · Estimate Of Fair Value Fair Value Disclosure | 724 | 250 | +189.6% |
Show — breakouts |
|||
| Short Term Borrowings | 724 | 250 | +189.6% |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure · Fair Value Measurements Nonrecurring | 724 | 250 | +189.6% |
| Estimate Of Fair Value Fair Value Disclosure · Fair Value Measurements Recurring | 724 | 250 | +189.6% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Current Portion of Long-Term Debt | 350 | — | — |
| Other Liabilities Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Liabilities Current | 13,985 | 11,426 | +22.4% |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 45,309 | 42,698 | +6.1% |
| Non-Current Liabilities | |||
| Available For Sale Securities Debt Securities Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Available For Sale Securities Debt Securities Noncurrent | 1,114 | 1,060 | +5.1% |
| Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Long-Term Debt | 30,768 | — | — |
| Deferred Tax Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Liabilities | 1,786 | 2,121 | -15.8% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 3,922 | 3,994 | -1.8% |
| Total Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities | 81,785 | 77,097 | +6.1% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Senior Unsecured Notes · Senior Notes | 31,093 | 29,728 | +4.6% |
| Surplus Notes | 25 | 25 | 0.0% |
Show — breakouts |
|||
| Long-Term Debt | 31,118 | — | — |
| Other Liabilities | |||
| Preferred Stock Shares Authorized (Q) | — | — | — |
Show — breakouts |
|||
| Preferred Stock Shares Authorized | 100,000,000 | — | — |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock | 2 | 2 | 0.0% |
| Additional Paid-In Capital (Q) | — | — | — |
Show — breakouts |
|||
| Additional Paid-In Capital | 8,845 | 8,866 | -0.2% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | 35,796 | 34,546 | +3.6% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -741 | -911 | +18.7% |
| Total Stockholders' Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Stockholders' Equity | 43,902 | 42,503 | +3.3% |
| Minority Interest (Q) | — | — | — |
Show — breakouts |
|||
| Minority Interest | 140 | 117 | +19.7% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest | -329 | -404 | +18.6% |
| Accumulated Net Investment Gain Loss Including Portion Attributable To Noncontrolling Interest | -167 | -289 | +42.2% |
| Additional Paid In Capital | 8,845 | 8,866 | -0.2% |
| AOCI, Other Components [Member] | -245 | -218 | -12.4% |
| Common Stock | 2 | 2 | 0.0% |
| Noncontrolling Interest | 140 | 117 | +19.7% |
| Retained Earnings | 35,796 | 34,546 | +3.6% |
Show — breakouts |
|||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 44,042 | 42,620 | +3.3% |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 125,827 | 119,717 | +5.1% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Income Loss From Equity Method Investments (Q) | — | — | — |
Show — breakouts |
|||
| Income Loss From Equity Method Investments | -305 | -126 | -142.1% |
| Depreciation Amortization And Accretion Net (Q) | — | — | — |
Show — breakouts |
|||
| Depreciation Amortization And Accretion Net | 354 | 373 | -5.1% |
| Deferred Income Taxes (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Income Taxes | -274 | -174 | -57.5% |
| Asset Impairment Charges (Q) | — | — | — |
Show — breakouts |
|||
| Asset Impairment Charges | 4 | — | — |
| Stock-Based Compensation (Q) | — | — | — |
Show — breakouts |
|||
| Stock-Based Compensation | 55 | 81 | -32.1% |
| Increase Decrease In Receivables (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Receivables | -1,174 | -3,174 | +63.0% |
| Increase Decrease In Other Operating Assets (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Other Operating Assets | -1,552 | -647 | -139.9% |
| Increase Decrease In Insurance Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Insurance Liabilities | 1,590 | 600 | +165.0% |
| Increase Decrease In Deferred Revenue (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Deferred Revenue | 266 | 132 | +101.5% |
| Increase Decrease In Accounts Payable And Other Operating Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Accounts Payable And Other Operating Liabilities | 2,886 | 952 | +203.2% |
| Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | 644 | 357 | +80.4% |
| Net Cash from Operations (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | 4,332 | 1,017 | +326.0% |
| Investing Activities | |||
| Payments To Acquire Investments (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Investments | -4,735 | -3,964 | -19.5% |
| Proceedsfromsaleofequityandfixedmaturitysecurities (Q) | — | — | — |
Show — breakouts |
|||
| Proceedsfromsaleofequityandfixedmaturitysecurities | 3,094 | 4,150 | -25.4% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 552 | 424 | +30.2% |
| Increase Decrease In Collateral Held Under Securities Lending (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Collateral Held Under Securities Lending | -313 | -290 | -7.9% |
| Payments To Acquire Businesses Net Of Cash Acquired (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Businesses Net Of Cash Acquired | 5 | 4 | +25.0% |
| Capital Expenditures (Q) | — | — | — |
Show — breakouts |
|||
| Capital Expenditures | -235 | -196 | -19.9% |
| Other Investing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Other Investing Activities | -10 | -25 | +60.0% |
| Net Cash from Investing (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | -1,642 | 103 | -1694.2% |
| Financing Activities | |||
| Repayments Of Long Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Repayments Of Long Term Debt | -750 | -1,250 | +40.0% |
| Proceeds From Short Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Short Term Debt | 724 | — | — |
| Repayments Of Short Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Repayments Of Short Term Debt | -150 | -115 | -30.4% |
| Increase Decrease In Securities Lending Payable (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Securities Lending Payable | 313 | 290 | +7.9% |
| Increase Decrease In Outstanding Checks Financing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Outstanding Checks Financing Activities | -1,152 | 546 | -311.0% |
| Share Repurchases (Q) | — | — | — |
Show — breakouts |
|||
| Share Repurchases | -1,124 | -880 | -27.7% |
| Payments Of Dividends (Q) | — | — | — |
Show — breakouts |
|||
| Payments Of Dividends | -376 | -386 | +2.6% |
| Proceeds From Stock Options Exercised (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Stock Options Exercised | 37 | 23 | +60.9% |
| Tax Withholding for Share Compensation (Q) | — | — | — |
Show — breakouts |
|||
| Tax Withholding for Share Compensation | -34 | -123 | +72.4% |
| Proceeds From Payments For Other Financing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Payments For Other Financing Activities | -3 | -14 | +78.6% |
| Net Cash from Financing (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | -2,515 | -1,909 | -31.7% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -9 | 1 | -1000.0% |
| Net Change in Cash (Q) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | 166 | -788 | +121.1% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9,657 | 7,500 | +28.8% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.